Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Market Cap | $47,444 | $161,406 | $37,422 | $37,422 |
| - Cash | $48,526 | $74,467 | $9,091 | $4,962 |
| + Debt | $30,125 | $0 | $0 | $0 |
| Enterprise Value | $29,043 | $86,939 | $28,331 | $32,460 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$157 | -$120 | -$67 | -$32 |
| % Margin | – | – | – | – |
| EBITDA | -$76,341 | -$48,451 | -$20,622 | -$11,078 |
| % Margin | – | – | – | – |
| Net Income | -$73,314 | -$50,545 | -$21,825 | -$11,294 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.59 | -5.19 | -11.23 | -5.81 |
| % Growth | 30.8% | 53.8% | -93.3% | – |
| Operating Cash Flow | -$61,693 | -$41,084 | -$17,682 | -$9,979 |
| Capital Expenditures | -$39 | -$274 | -$238 | -$88 |
| Free Cash Flow | -$61,732 | -$41,358 | -$17,920 | -$10,067 |